Blocking the Brain's Endocannabinoid System Triggered a Full Stress Response in Rats, Even Without Any Stressor
Disrupting endocannabinoid signaling in the brain with multiple different approaches all uniformly triggered stress hormone release, stress behaviors, and stress neuron activation, proving that the endocannabinoid system actively suppresses the stress response at rest.
Quick Facts
What This Study Found
CB1 receptor antagonist/inverse agonist AM251, neutral antagonist NESS243, and NAPE-PLD inhibitor LEI401 all uniformly increased PVN Fos expression, unmasked stress-linked behaviors (grooming), and increased circulating corticosterone, mimicking the effects of actual stress. Direct PVN administration of AM251 produced the same effects. Optogenetic inhibition of PVN CRH neurons ameliorated the behavioral changes, confirming these neurons mediate the effect.
Key Numbers
Three different pharmacological approaches all produced uniform stress responses. Direct PVN administration confirmed local mechanism. Optogenetic CRH neuron inhibition reversed behavioral effects.
How They Did This
Multiple approaches to disrupt endocannabinoid signaling in rats: systemic CB1 antagonism (AM251, NESS243), endocannabinoid synthesis inhibition (LEI401), and direct PVN CB1 blockade. Outcomes: PVN Fos expression, circulating corticosterone, stress behaviors. Optogenetic CRH neuron inhibition for causal verification.
Why This Research Matters
This study provides definitive evidence that the endocannabinoid system is not just involved in stress modulation but actively restrains the stress response at all times. Without this constant endocannabinoid "brake," the body generates a full stress response even in the absence of any actual threat.
The Bigger Picture
This explains why cannabis withdrawal often produces intense anxiety and stress: removing exogenous cannabinoids after the endocannabinoid system has adapted means the stress brake is temporarily weakened. It also explains the psychiatric side effects of rimonabant (a CB1 antagonist that was withdrawn as a weight-loss drug due to anxiety and depression).
What This Study Doesn't Tell Us
Animal study that may not directly translate to humans. Pharmacological agents have off-target effects. Acute disruption differs from chronic endocannabinoid deficiency. Optogenetic tools, while powerful, involve artificial neural manipulation.
Questions This Raises
- ?Could endocannabinoid deficiency explain chronic stress and anxiety disorders in humans?
- ?Would boosting endocannabinoid tone be a viable treatment for stress-related psychiatric conditions?
Trust & Context
- Key Stat:
- Blocking endocannabinoids triggered full stress response even without any actual stressor
- Evidence Grade:
- Rigorous animal study using multiple converging approaches with optogenetic causal verification.
- Study Age:
- Published 2023.
- Original Title:
- Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.
- Published In:
- British journal of pharmacology, 180(24), 3146-3159 (2023)
- Authors:
- Petrie, Gavin N(6), Balsevich, Georgia, Füzesi, Tamás, Aukema, Robert J, Driever, Wouter P F, van der Stelt, Mario, Bains, Jaideep S, Hill, Matthew N
- Database ID:
- RTHC-04849
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does the endocannabinoid system control stress?
Yes. This study showed that blocking endocannabinoid signaling through three different methods all triggered full stress responses in rats, including stress hormones and anxiety behaviors, even without any stressor present.
Why does cannabis withdrawal cause anxiety?
This study helps explain it: the endocannabinoid system constantly suppresses stress responses. When this system is disrupted (as during withdrawal), the stress brake is released, triggering anxiety and stress even without an external cause.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-04849APA
Petrie, Gavin N; Balsevich, Georgia; Füzesi, Tamás; Aukema, Robert J; Driever, Wouter P F; van der Stelt, Mario; Bains, Jaideep S; Hill, Matthew N. (2023). Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.. British journal of pharmacology, 180(24), 3146-3159. https://doi.org/10.1111/bph.16198
MLA
Petrie, Gavin N, et al. "Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.." British journal of pharmacology, 2023. https://doi.org/10.1111/bph.16198
RethinkTHC
RethinkTHC Research Database. "Disruption of tonic endocannabinoid signalling triggers cell..." RTHC-04849. Retrieved from https://rethinkthc.com/research/petrie-2023-disruption-of-tonic-endocannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.